Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTPS1 | P17812 | 20/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29791394 | 1.00 | CTPS1 (0.78) | CTPS1 | |
| SCHEMBL22758517 | 0.94 | CTPS1 (0.79) | CTPS1 | |
| SCHEMBL29508490 | 0.94 | CTPS1 (0.79) | CTPS1 | |
| SCHEMBL22749250 | 0.93 | CTPS1 (0.84) | CTPS1 | |
| SCHEMBL24849019 | 0.91 | CTPS1 (0.81) | CTPS1 | |
| SCHEMBL22736740 | 0.90 | CTPS1 (0.84) | CTPS1 | |
| SCHEMBL24849352 | 0.89 | CTPS1 (0.78) | CTPS1 | |
| SCHEMBL23120976 | 0.89 | CTPS1 (0.78) | CTPS1 | |
| SCHEMBL22749224 | 0.89 | CTPS1 (0.78) | CTPS1 | |
| SCHEMBL29369234 | 0.89 | CTPS1 (0.78) | CTPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230020663-A1 | SULFONAMIDE INHIBITORS AS CTPS1 INHIBITORS | STEP PHARMA S.A.S. (FR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230020663-A1 | SULFONAMIDE INHIBITORS AS CTPS1 INHIBITORS | CTPS1, CTPS2, TYMS | CTPS1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.